BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12873680)

  • 21. Incorporation of SPECT bone marrow imaging into intensity modulated whole-pelvic radiation therapy treatment planning for gynecologic malignancies.
    Roeske JC; Lujan A; Reba RC; Penney BC; Diane Yamada S; Mundt AJ
    Radiother Oncol; 2005 Oct; 77(1):11-7. PubMed ID: 16024116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size.
    Ahamad A; D'Souza W; Salehpour M; Iyer R; Tucker SL; Jhingran A; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1117-24. PubMed ID: 15990017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-volume analysis of predictors for chronic gastrointestinal complications in patients with cervical cancer treated with postoperative concurrent chemotherapy and whole-pelvic radiation therapy.
    Isohashi F; Mabuchi S; Akino Y; Yoshioka Y; Seo Y; Suzuki O; Tamari K; Yoshino K; Sawada K; Ueda Y; Kobayashi E; Sumida I; Mizuno H; Okubo H; Kimura T; Ogawa K
    J Radiat Res; 2016 Nov; 57(6):668-676. PubMed ID: 27342839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NTCP modeling analysis of acute hematologic toxicity in whole pelvic radiation therapy for gynecologic malignancies - A dosimetric comparison of IMRT and spot-scanning proton therapy (SSPT).
    Yoshimura T; Kinoshita R; Onodera S; Toramatsu C; Suzuki R; Ito YM; Takao S; Matsuura T; Matsuzaki Y; Umegaki K; Shirato H; Shimizu S
    Phys Med; 2016 Sep; 32(9):1095-102. PubMed ID: 27567089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms.
    Heron DE; Gerszten K; Selvaraj RN; King GC; Sonnik D; Gallion H; Comerci J; Edwards RP; Wu A; Andrade RS; Kalnicki S
    Gynecol Oncol; 2003 Oct; 91(1):39-45. PubMed ID: 14529660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study.
    Chan P; Yeo I; Perkins G; Fyles A; Milosevic M
    Radiat Oncol; 2006 May; 1():13. PubMed ID: 16722546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.
    Arcangeli S; Saracino B; Petrongari MG; Gomellini S; Marzi S; Landoni V; Gallucci M; Sperduti I; Arcangeli G
    Radiother Oncol; 2007 Aug; 84(2):148-55. PubMed ID: 17692416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fractionated stereotactic radiotherapy boost for gynecologic tumors: an alternative to brachytherapy?
    Mollà M; Escude L; Nouet P; Popowski Y; Hidalgo A; Rouzaud M; Linero D; Miralbell R
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):118-24. PubMed ID: 15850911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Setup errors in patients treated with intensity-modulated whole pelvic radiation therapy for gynecological malignancies.
    Haslam JJ; Lujan AE; Mundt AJ; Bonta DV; Roeske JC
    Med Dosim; 2005; 30(1):36-42. PubMed ID: 15749010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensity-modulated radiotherapy reduces gastrointestinal toxicity in pelvic radiation therapy with moderate dose.
    Kwak YK; Lee SW; Kay CS; Park HH
    PLoS One; 2017; 12(8):e0183339. PubMed ID: 28846718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel conformal arc technique for postoperative whole pelvic radiotherapy for endometrial cancer.
    Yang R; Jiang W; Wang J
    Int J Gynecol Cancer; 2009 Dec; 19(9):1574-9. PubMed ID: 19955940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcomes using adjuvant pelvic intensity modulated radiation therapy (IMRT) for endometrial carcinoma.
    He S; Gill BS; Heron DE; Kelley JL; Sukumvanich P; Olawaiye AB; Edwards RP; Comerci J; Beriwal S
    Pract Radiat Oncol; 2017; 7(1):19-25. PubMed ID: 27527897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate.
    Schultheiss TE; Hanks GE; Hunt MA; Lee WR
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):643-9. PubMed ID: 7790250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elective pelvic irradiation in prostate cancer patients with biochemical failure following radical prostatectomy: A propensity score matching analysis.
    Song C; Byun SJ; Kim YS; Ahn H; Byun SS; Kim CS; Lee SE; Kim JS
    PLoS One; 2019; 14(4):e0215057. PubMed ID: 30973905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-pelvic radiotherapy with spot-scanning proton beams for uterine cervical cancer: a planning study.
    Hashimoto S; Shibamoto Y; Iwata H; Ogino H; Shibata H; Toshito T; Sugie C; Mizoe JE
    J Radiat Res; 2016 Sep; 57(5):524-532. PubMed ID: 27380800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies.
    Milby AB; Both S; Ingram M; Lin LL
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e477-84. PubMed ID: 22177626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies.
    Kasibhatla M; Clough RW; Montana GS; Oleson JR; Light K; Steffey BA; Jones EL
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):398-403. PubMed ID: 16542793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival Outcomes of Whole-Pelvic Versus Prostate-Only Radiation Therapy for High-Risk Prostate Cancer Patients With Use of the National Cancer Data Base.
    Amini A; Jones BL; Yeh N; Rusthoven CG; Armstrong H; Kavanagh BD
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1052-63. PubMed ID: 26581142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematologic Toxicity in Patients Treated With Postprostatectomy Whole-Pelvis Irradiation With Different Intensity Modulated Radiation Therapy Techniques Is Not Negligible and Is Prolonged: Preliminary Results of a Longitudinal, Observational Study.
    Cozzarini C; Noris Chiorda B; Sini C; Fiorino C; Briganti A; Montorsi F; Di Muzio N
    Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):690-5. PubMed ID: 27131081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.